NeOnc Technologies (NTHI) announced that it has entered into a securities purchase agreement for a private investment in public equity for the purchase and sale of up to 2,222,222 shares of common stock and five-year warrants to purchase up to 2,222,222 shares of common stock at a per share exercise price of $9.00 at a combined purchase price of $7.20, that is expected to result in gross proceeds of up to approximately $16 million to the Company. NeOnc currently intends to use the net proceeds from the offering for repayment of indebtedness, and for working capital and corporate purposes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTHI:
- NeOnc Technologies Announces Private Placement Equity Financing Deal
- NeOnc’s Intranasal NEO100 Trial Marks a New Step in Pediatric Brain Tumor Investing
- NeOnc’s NEO100 Brain Tumor Trial Progresses, Keeping a Key Catalyst in Play for Investors
- NeOnc’s NEO212 Brain Cancer Trial Progresses: What Investors Should Watch Now
- NeOnc Technologies Reports Promising Clinical Trial Results
